When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells—the immune ...
Jul 2, 2025
0
2
A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the way for new treatment ...
Jul 1, 2025
0
3
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, multiple sclerosis, shows a new study in mice.
Jun 30, 2025
0
30
A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and clinicians unique insight into brain function and disease, researchers at the University of Illinois Urbana-Champaign ...
Jun 24, 2025
0
43
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.
Jun 24, 2025
0
0
A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual ...
Jun 23, 2025
0
0
Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement and balance, potentially ...
Jun 16, 2025
0
130
Primary sclerosis cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition for which we currently have no effective treatments and often results in the patient requiring a ...
Jun 11, 2025
0
0
Researchers from the University of California San Diego School of Medicine have discovered that children living with multiple sclerosis (MS) show signs of accelerated biological aging, even in their teenage years. The research, ...
Jun 9, 2025
0
0
Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and Heidelberg University Hospital (UKHD) have investigated potential risk factors for multiple sclerosis (MS) in childhood and adolescence as part of the ...
May 30, 2025
0
0
